Aspergillus Pneumonia in pos-COVID-19 patient

Authors

Keywords:

aspergillus, critical care, coronavirus infections, pneumonia.

Abstract

Introduction: The new SARS-CoV-2 coronavirus disease (COVID-19) spread rapidly throughout the world, which created a great challenge. The appearance of coinfections is among the most serious complications that these patients can develop. Pulmonary aspergillosis has been identified as a complication of COVID-19 pneumonia among ventilated patients in intensive care.
Objective: To present an unusual clinical case of pulmonary aspergillosis.
Clinical case: It is presented the case of a patient with a recent history of COVID-19, with an enteral clinical picture of diarrhea and vomiting plus respiratory failure, in which the evolution of colon cancer and ventilator-associated pneumonia caused by Aspergillus niger are concomitant.
Conclusions: Pulmonary aspergillosis associated with COVID-19 is a complication that should be considered and sought in patients with a recent history of this disease.

Downloads

Download data is not yet available.

Author Biographies

Jorge Alain Caballero Font, Hospital Universitario Arnaldo Milián Castro

Especialista de 2do Grado en Medicina Intensiva y Emergencias, Profesor Asistente, Investigador Agregado, Unidad de Cuidados Intensivos Hospital Universitario Arnaldo Milián Castro Actualmente de Misión Internacionalista en el Hospital Cubano de Dukhan en Catar

Armando Caballero López, Hospital Universitario Arnaldo Milián Castro

Esp. 2do grado en Anestesiología y Reanimación y Medicina Intensiva y Emergencias, Doctor en Ciencias Médicas, Profesor Titular, Asistente extranjero de los hospitales de París. Presidente del Comité Académico de la Especialidad de Medicina Intensiva y Emergencias en Villa Clara

Osmani Pérez Ortiz, Hospital Universitario Mártires del 9 de abril

Esp 1er grado en Medicina Intensiva y Emergencias, Unidad de Cuidados Intensivos Hospital Universitario Mártires del 9 de abril

References

1. Schauwvlieghe AFAD, Rijnders BJA, Philips N, Verwijs R, Vanderbeke L, Van Tienen C, et al. Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study. Lancet Respir Med. 2018(10):782-92. DOI: 10.1016/S2213-2600(18)30274-1

2. Marr KA, Platt A, Tornheim JA, Zhang SX, Datta K, Cardozo C, et al. Aspergillosis Complicating Severe Coronavirus Disease. Emerg Infect Dis. 2020 [acceso: 15/12/2021]; 27(1):18-25. Disponible en: https://pubmed.ncbi.nlm.nih.gov/33084566

3. Salmanton-García J, Sprute R, Stemler J, Bartoletti M, Dupont D, Valerio M, et al. COVID-19-Associated Pulmonary Aspergillosis, March-August 2020. Emerg Infect Dis. 2021 [acceso: 06/01/2022]; 27(4):1077-86. Disponible en: https://pubmed.ncbi.nlm.nih.gov/33539721

4. Machado M, Valerio M, Álvarez-Uría A, Olmedo M, Veintimilla C, Padilla B, et al. Invasive pulmonary aspergillosis in the COVID-19 era: An expected new entity. Mycoses. 2021 [acceso: 15/12/2021]; 64(2):132-43. Disponible en: https://pubmed.ncbi.nlm.nih.gov/33210776

5. Fekkar A, Lampros A, Mayaux J, Poignon C, Demeret S, Constantin J-M, et al. Occurrence of Invasive Pulmonary Fungal Infections in Patients with Severe COVID-19 Admitted to the ICU. Am J Respir Crit Care Med. 2021 [acceso: 15/12/2021]; 203(3):307-17. Disponible en: https://www.atsjournals.org/doi/10.1164/rccm.202009-3400OC

6. Dupont D, Menotti J, Turc J, Miossec C, Wallet F, Richard J-C, et al. Pulmonary aspergillosis in critically ill patients with Coronavirus Disease 2019 (COVID-19). Med Mycol. 2021 [acceso: 15/12/2021]; 59(1):110-4. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32914189

7. Bartoletti M, Pascale R, Cricca M, Rinaldi M, Maccaro A, Bussini L, et al. Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study. Clin Infect Dis. 2021 [acceso: 01/08/2022]; 73(11):e3606-14. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7454393/pdf/ciaa1065.pdf

8. van Arkel ALE, Rijpstra TA, Belderbos HNA, van Wijngaarden P, Verweij PE, Bentvelsen RG. COVID-19-associated Pulmonary Aspergillosis. Am J Respir Crit Care Med. 2020; 202(1):132-5. DOI: 10.1164/rccm.202004-1038LE

9. Verweij PE, Gangneux J-P, Bassetti M, Brüggemann RJM, Cornely OA, Koehler P, et al. Diagnosing COVID-19-associated pulmonary aspergillosis. The Lancet Microbe. 2020; 1(2):e53-5. DOI: 10.1016/S2666-5247(20)30027-6

10. Koehler P, Cornely OA, Böttiger BW, Dusse F, Eichenauer DA, Fuchs F, et al. COVID-19 associated pulmonary aspergillosis. Mycoses. 2020; 63(6):528-34. DOI: 10.1111/myc.13096

11. Borman AM, Palmer MD, Fraser M, Patterson Z, Mann C, Oliver D, et al. COVID-19-Associated Invasive Aspergillosis: Data from the UK National Mycology Reference Laboratory. Hanson KE, editor. J Clin Microbiol. 2020 [acceso: 15/12/2021]; 59(1):e02136-20. Disponible en: https://pubmed.ncbi.nlm.nih.gov/33087440

12. Lai C-C, Yu W-L. COVID-19 associated with pulmonary aspergillosis: A literature review. J Microbiol Immunol Infect. 2021 [acceso: 15/12/2021]; 54(1):46-53. Disponible en: https://pubmed.ncbi.nlm.nih.gov/33012653

Downloads

Published

2023-12-21

How to Cite

1.
Caballero Font JA, Caballero López A, Pérez Ortiz O. Aspergillus Pneumonia in pos-COVID-19 patient. Rev Cubana Med Milit [Internet]. 2023 Dec. 21 [cited 2025 Feb. 1];53(1):e024024881. Available from: https://revmedmilitar.sld.cu/index.php/mil/article/view/24881

Issue

Vol. 53 No. 1 (2024): January - March

Section

Case Presentation

License

Authors who have publications with this Journal accept the following terms:

  • The authors will retain their copyright and guarantee the Journal the right of first publication of their work, which will simultaneously be subject to the Creative Commons Attribution License. The content presented here can be shared, copied and redistributed in any medium or format; Can be adapted, remixed, transformed or created from the material, using the following terms: Attribution (giving appropriate credit to the work, providing a link to the license, and indicating if changes have been made); non-commercial (you cannot use the material for commercial purposes) and share-alike (if you remix, transform or create new material from this work, you can distribute your contribution as long as you use the same license as the original work).
  • The authors may adopt other non-exclusive license agreements for the distribution of the published version of the work (for example: depositing it in an institutional electronic archive or publishing it in a monographic volume) as long as the initial publication in this Journal is indicated.
  • Authors are allowed and recommended to disseminate their work through the Internet (e.g., in institutional electronic archives or on their website) before and during the submission process, which can produce interesting exchanges and increase citations. of the published work.